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Background: The contemporary treatments and outcomes for U.S. patients (pts) who present with angiographic stent thrombosis (ST) resulting in 
acute coronary syndromes (ACS) are not well described.
Methods: 113 consecutive episodes of angiographically confirmed ST in 106 pts from Jan 2005 - Sep 2009 in 2 academic medical centers were 
retrospectively analyzed.
Results: Clinical and procedural characteristics are reported (Table). Hospital mortality was low (5.6%). Over one-half (50.5%) of thrombotic 
events occurred > 1 year after index stent implantation. 7 pts (6.5%) underwent coronary bypass surgery, and 7 pts had recurrent thrombotic events. 
38.9% of pts were on dual antiplatelet therapy at the time of presentation, while 23.0% were not on either aspirin or a thienopyridine. Intravascular 
ultrasound was performed in 30 pts (27.8%), of which 38.2% showed mal-apposition and 29.4% showed stent under-expansion. On univariate 
analysis, age, diabetes mellitus, dialysis, tobacco use, index stent type or clinical presentation were not predictive of mortality. Female gender 
(p=0.08) and cardiogenic shock at the time of presentation were associated with a trend towards mortality (p=0.06). LVEF <40% was significantly 
associated with hospital mortality (p=0.0014).
Conclusions: Angiographically confirmed very late stent thrombosis occurred in 51% of pts presenting with ACS and ST. Hospital mortality was 
lower than previously reported and LVEF <40% was the only univariate predictor of hospital mortality. 
Clinical and Procedural Characteristics of Coronary Artery Stent Thromboses
Age (years) 60.3± 13.8
Length of stay (days) 7.2 ± 7.5
Time from previous stent (days) 642 ± 784
Male gender 80.0 %
Diabetes mellitus 31.5%
Hypertension 79.3 %
LVEF 46.3 ± 13.2 %
Tobacco use (current and prior) 61.4%
On aspirin prior to event 67.6 %
On thienopyridine prior to event 45.0 %
Aspirin at discharge 99.9 %
Thienopyridine at discharge 96.9 %
Cardiogenic shock 18.3%
Recurrent (≥ 2) stent thromboses, n (%) 7 (6.2%)
Timing of thromboses
Acute (< 24 hours)
Subacute (1-30 days)
Late (31-365 days)
Very Late (>365 days)
3.0 %
23.8 %
22.7 %
50.5%
Thrombosed stent
DES
BMS
Unknown
46.8%
27.5%
25.7%
POBA without stenting 29.4 %
Thrombectomy device used 55.0%
IVUS performed 27.8%
Stent used to treat thrombosis
DES implanted
BMS implanted
70.6 %
64.7 %
35.3%
Procedural success 91.4 %
Death, n (%) 6 (5.6 %)
